SLC38A2 and pancreatic adenocarcinoma: In terms of progression-free interval (PFI), SLC38A2 is a risk factor for LUAD (HR = 1.666, p < 0.01) and PAAD (HR = 1.766, p < 0.05) (Figure 2C).